Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-007977

Chief Commercial Officer, SaaS sold 9,113 shares at an average $235.40 ($2,145,186)

  • Chief Commercial Officer, SaaS acquired 9,113 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Option exercise 10b5-1 +367 $211.76 $77,716 10,092 D
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Option exercise 10b5-1 +3,506 $146.34 $513,068 13,598 D
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Option exercise 10b5-1 +514 $146.34 $75,219 14,112 D
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Option exercise 10b5-1 +4,726 $211.76 $1,000,778 18,838 D
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Sale 10b5-1 −367 $235.25 $86,336 18,471 D
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Sale 10b5-1 −3,506 $235.40 $825,308 14,965 D
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Sale 10b5-1 −514 $235.25 $120,918 14,451 D
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Sale 10b5-1 −4,726 $235.43 $1,112,624 9,725 D
Derivatives
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Option exercise · ResMed Common Stock Options 10b5-1 −367 105 D
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Option exercise · ResMed Common Stock Options 10b5-1 −3,506 3,589 D
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Option exercise · ResMed Common Stock Options 10b5-1 −514 169 D
Ghoshal Kaushik Chief Commercial Officer, SaaS 2025-03-03 Option exercise · ResMed Common Stock Options 10b5-1 −4,726 5,882 D
Open-market sales · 9,113 sh · avg $235.40 · $2,145,186
Loading xslF345X05/form4.xml…